Rankia USA Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia España Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
14,477 / 16,979
#115809

Re: Farmas USA

Lo que consiga es gracias a vuestra maestria. Lo poco que se de este tipo de operativa lo he aprendido de vosotros.

 

Gracias!!!

#115815

Re: Farmas USA

De momento veo caso todas las que sigo o tengo en rojo excepto Nvax. Pero...todas con unas cantidades de acciones irrisorias. Espero que con eso no tumben los precios..
Ejemplo gncea -9% con 1000 acciones.

#115816

Re: Farmas USA


  • Amarin (NASDAQ:
    AMRN) initiated with Outperform rating and $26 (82% upside) price target at SVB Leerink.

  • Tenet Healthcare (NYSE:
    THC) resumed with Neutral rating and $28 (32% upside) price target at Goldman Sachs.

  • Bristol-Myers Squibb (NYSE:
    BMY) upgraded to Overweight with a $63 (36% upside) price target at Atlantic Equities.

  • Horizon Therapeutics (NASDAQ:
    HZNP) upgraded to Outperform with a $36 (36% upside) price target at BMO Capital Markets.

  • Avedro (NASDAQ:
    AVDR) downgraded to Neutral with a $26 (16% upside) price target at JPMorgan.

  • Myriad Genetics (NASDAQ:
    MYGN) downgraded to Neutral with a $40 (10% downside risk) price target at Piper Jaffray. Shares down 27% premarket on FQ4 miss.

  • Acorda Therapeutics (NASDAQ:
    ACOR) downgraded to Neutral with a $6 (120% upside) price target at H.C. Wainwright. Shares down 4% premarket.

Te puede interesar...

- No hay entradas a destacar -

- No hay entradas a destacar -

Brokers destacados